Cell and Tissue Research

, Volume 343, Issue 1, pp 153–165

NF-κB and STAT3 signaling hubs for lung innate immunity



Innate immune responses to lung pathogens involve the coordinated expression of myriad affector and effector molecules of innate immunity, which must be induced and appropriately regulated in response to diverse stimuli generated by microbes or the infected host. Many intercellular and intracellular signaling pathways are involved, but we propose NF-κB and STAT3 transcription factors to be especially important signaling hubs for integrating these pathways to orchestrate effective host defense without excessive inflammatory injury.


Pneumonia Innate immunity NF-ĸB STAT3 Transcriptional regulation 


  1. Akira S, Nishio Y, Inoue M, Wang XJ, Wei S, Matsusaka T, Yoshida K, Sudo T, Naruto M, Kishimoto T (1994) Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway. Cell 77:63–71PubMedCrossRefGoogle Scholar
  2. Alcamo EA, Mizgerd JP, Horwitz BH, Bronson R, Beg AA, Scott M, Doerschuk CM, Hynes RO, Baltimore D (2001) Targeted mutation of tumor necrosis factor 1 rescues the RelA-deficient mouse and reveals a critical role for NF-kB in leukocyte recruitment. J Immunol 167:1592–1600PubMedGoogle Scholar
  3. Almirall J, Bolibar I, Toran P, Pera G, Boquet X, Balanzo X, Sauca G (2004) Contribution of C-reactive protein to the diagnosis and assessment of severity of community-acquired pneumonia. Chest 125:1335–1342PubMedCrossRefGoogle Scholar
  4. Alonzi T, Maritano D, Gorgoni B, Rizzuto G, Libert C, Poli V (2001) Essential role of STAT3 in the control of the acute-phase response as revealed by inducible gene inactivation [correction of activation] in the liver. Mol Cell Biol 21:1621–1632PubMedCrossRefGoogle Scholar
  5. Anderson P (2010) Post-transcriptional regulons coordinate the initiation and resolution of inflammation. Nat Rev Immunol 10:24–35PubMedCrossRefGoogle Scholar
  6. Andus T, Geiger T, Hirano T, Kishimoto T, Heinrich PC (1988) Action of recombinant human interleukin 6, interleukin 1 beta and tumor necrosis factor alpha on the mRNA induction of acute-phase proteins. Eur J Immunol 18:739–746PubMedCrossRefGoogle Scholar
  7. Armstrong GL, Conn LA, Pinner RW (1999) Trends in infectious disease mortality in the United States during the 20th century. JAMA 281:61–66PubMedCrossRefGoogle Scholar
  8. Aujla SJ, Chan YR, Zheng M, Fei M, Askew DJ, Pociask DA, Reinhart TA, McAllister F, Edeal J, Gaus K, Husain S, Kreindler JL, Dubin PJ, Pilewski JM, Myerburg MM, Mason CA, Iwakura Y, Kolls JK (2008) IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat Med 14:275–281PubMedCrossRefGoogle Scholar
  9. Awomoyi AA, Rallabhandi P, Pollin TI, Lorenz E, Sztein MB, Boukhvalova MS, Hemming VG, Blanco JC, Vogel SN (2007) Association of TLR4 polymorphisms with symptomatic respiratory syncytial virus infection in high-risk infants and young children. J Immunol 179:3171–3177PubMedGoogle Scholar
  10. Bazzoni F, Rossato M, Fabbri M, Gaudiosi D, Mirolo M, Mori L, Tamassia N, Mantovani A, Cassatella MA, Locati M (2009) Induction and regulatory function of miR-9 in human monocytes and neutrophils exposed to proinflammatory signals. Proc Natl Acad Sci USA 106:5282–5287PubMedCrossRefGoogle Scholar
  11. Beg AA, Sha WC, Bronson RT, Baltimore D (1995a) Constitutive NF-kB activation, enhanced granulopoiesis, and neonatal lethality in IkBa-deficient mice. Genes Dev 9:2736–2746PubMedCrossRefGoogle Scholar
  12. Beg AA, Sha WC, Bronson RT, Ghosh S, Baltimore D (1995b) Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature 376:167–170PubMedCrossRefGoogle Scholar
  13. Bernuth H von, Picard C, Jin Z, Pankla R, Xiao H, Ku CL, Chrabieh M, Mustapha IB, Ghandil P, Camcioglu Y, Vasconcelos J, Sirvent N, Guedes M, Vitor AB, Herrero-Mata MJ, Arostegui JI, Rodrigo C, Alsina L, Ruiz-Ortiz E, Juan M, Fortuny C, Yague J, Anton J, Pascal M, Chang HH, Janniere L, Rose Y, Garty BZ, Chapel H, Issekutz A, Marodi L, Rodriguez-Gallego C, Banchereau J, Abel L, Li X, Chaussabel D, Puel A, Casanova JL (2008) Pyogenic bacterial infections in humans with MyD88 deficiency. Science 321:691–696CrossRefGoogle Scholar
  14. Betts JC, Cheshire JK, Akira S, Kishimoto T, Woo P (1993) The role of NF-kappa B and NF-IL6 transactivating factors in the synergistic activation of human serum amyloid A gene expression by interleukin-1 and interleukin-6. J Biol Chem 268:25624–25631PubMedGoogle Scholar
  15. Bicknell S, Eeden S van, Hayashi S, Hards J, English D, Hogg JC (1994) A non-radioisotopic method for tracing neutrophils in vivo using 5′-bromo-2′-deoxyuridine. Am J Respir Cell Mol Biol 10:16–23PubMedGoogle Scholar
  16. Bochud PY, Chien JW, Marr KA, Leisenring WM, Upton A, Janer M, Rodrigues SD, Li S, Hansen JA, Zhao LP, Aderem A, Boeckh M (2008) Toll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation. N Engl J Med 359:1766–1777PubMedCrossRefGoogle Scholar
  17. Bousfiha A, Picard C, Boisson-Dupuis S, Zhang SY, Bustamante J, Puel A, Jouanguy E, Ailal F, El-Baghdadi J, Abel L, Casanova JL (2010) Primary immunodeficiencies of protective immunity to primary infections. Clin Immunol 135:204–209PubMedCrossRefGoogle Scholar
  18. Boutten A, Dehoux MS, Seta N, Ostinelli J, Venembre P, Crestani B, Dombret MC, Durand G, Aubier M (1996) Compartmentalized IL-8 and elastase release within the human lung in unilateral pneumonia. Am J Respir Crit Care Med 153:336–342PubMedGoogle Scholar
  19. Branger J, Florquin S, Knapp S, Leemans JC, Pater JM, Speelman P, Golenbock DT, Poll T van der (2004) LPS-binding protein-deficient mice have an impaired defense against Gram-negative but not Gram-positive pneumonia. Int Immunol 16:1605–1611PubMedCrossRefGoogle Scholar
  20. Brass DM, Savov JD, Whitehead GS, Maxwell AB, Schwartz DA (2004) LPS binding protein is important in the airway response to inhaled endotoxin. J Allergy Clin Immunol 114:586–592PubMedCrossRefGoogle Scholar
  21. Carvalho A, Pasqualotto AC, Pitzurra L, Romani L, Denning DW, Rodrigues F (2008) Polymorphisms in toll-like receptor genes and susceptibility to pulmonary aspergillosis. J Infect Dis 197:618–621PubMedCrossRefGoogle Scholar
  22. Cheng JD, Ryseck RP, Attar RM, Dambach D, Bravo R (1998) Functional redundancy of the nuclear factor kB inhibitors IkB-a and IkB-b. J Exp Med 188:1055–1062PubMedCrossRefGoogle Scholar
  23. Cheng DS, Han W, Chen SM, Sherrill TP, Chont M, Park GY, Sheller JR, Polosukhin VV, Christman JW, Yull FE, Blackwell TS (2007) Airway epithelium controls lung inflammation and injury through the NF-kappa B pathway. J Immunol 178:6504–6513PubMedGoogle Scholar
  24. Clarke TB, Davis KM, Lysenko ES, Zhou AY, Yu Y, Weiser JN (2010) Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity. Nat Med 16:228–231PubMedCrossRefGoogle Scholar
  25. Demetri GD, Griffin JD (1991) Granulocyte colony-stimulating factor and its receptor. Blood 78:2791–2808PubMedGoogle Scholar
  26. Dunn SM, Coles LS, Lang RK, Gerondakis S, Vadas MA, Shannon MF (1994) Requirement for nuclear factor (NF)-kappa B p65 and NF-interleukin-6 binding elements in the tumor necrosis factor response region of the granulocyte colony-stimulating factor promoter. Blood 83:2469–2479PubMedGoogle Scholar
  27. Fan MH, Klein RD, Steinstraesser L, Merry AC, Nemzek JA, Remick DG, Wang SC, Su GL (2002) An essential role for lipopolysaccharide-binding protein in pulmonary innate immune responses. Shock 18:248–254PubMedCrossRefGoogle Scholar
  28. Fong CH, Bebien M, Didierlaurent A, Nebauer R, Hussell T, Broide D, Karin M, Lawrence T (2008) An antiinflammatory role for IKKbeta through the inhibition of "classical" macrophage activation. J Exp Med 205:1269–1276PubMedCrossRefGoogle Scholar
  29. Freeman AF, Holland SM (2009) Clinical manifestations, etiology, and pathogenesis of the hyper-IgE syndromes. Pediatr Res 65:32R–37RPubMedCrossRefGoogle Scholar
  30. Freeman AF, Kleiner DE, Nadiminti H, Davis J, Quezado M, Anderson V, Puck JM, Holland SM (2007) Causes of death in hyper-IgE syndrome. J Allergy Clin Immunol 119:1234–1240PubMedCrossRefGoogle Scholar
  31. Gabay C, Kushner I (1999) Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340:448–454PubMedCrossRefGoogle Scholar
  32. Gadjeva M, Tomczak MF, Zhang M, Wang YY, Dull K, Rogers AB, Erdman SE, Fox JG, Carroll M, Horwitz BH (2004) A role for NF-kappa B subunits p50 and p65 in the inhibition of lipopolysaccharide-induced shock. J Immunol 173:5786–5793PubMedGoogle Scholar
  33. Gamble L, Bagby GJ, Quinton LJ, Happel KI, Mizgerd JP, Zhang P, Nelson S (2008) The systemic and pulmonary lipopolysaccharide binding protein response to intratracheal lipopolysaccharide. Shock 31:212–217CrossRefGoogle Scholar
  34. Gao H, Guo RF, Speyer CL, Reuben J, Neff TA, Hoesel LM, Riedemann NC, McClintock SD, Sarma JV, Van Rooijen N, Zetoune FS, Ward PA (2004) Stat3 activation in acute lung injury. J Immunol 172:7703–7712PubMedGoogle Scholar
  35. Geisler F, Algul H, Paxian S, Schmid RM (2007) Genetic inactivation of RelA/p65 sensitizes adult mouse hepatocytes to TNF-induced apoptosis in vivo and in vitro. Gastroenterology 132:2489–2503PubMedCrossRefGoogle Scholar
  36. Gennery AR, Flood TJ, Abinun M, Cant AJ (2000) Bone marrow transplantation does not correct the hyper IgE syndrome. Bone Marrow Transplant 25:1303–1305PubMedCrossRefGoogle Scholar
  37. Genovese MC, Cohen S, Moreland L, Lium D, Robbins S, Newmark R, Bekker P (2004) Combination therapy with etanercept and anakinra in the treatment of patients with rheumatoid arthritis who have been treated unsuccessfully with methotrexate. Arthritis Rheum 50:1412–1419PubMedCrossRefGoogle Scholar
  38. Gough DJ, Corlett A, Schlessinger K, Wegrzyn J, Larner AC, Levy DE (2009) Mitochondrial STAT3 supports Ras-dependent oncogenic transformation. Science 324:1713–1716PubMedCrossRefGoogle Scholar
  39. Greenberger MJ, Strieter RM, Kunkel SL, Danforth JM, Laichalk LL, McGillicuddy DC, Standiford TJ (1996) Neutralization of macrophage inflammatory protein-2 attenuates neutrophil recruitment and bacterial clearance in murine Klebsiella pneumonia. J Infect Dis 173:159–165PubMedGoogle Scholar
  40. Gregory AD, Hogue LA, Ferkol TW, Link DC (2007) Regulation of systemic and local neutrophil responses by G-CSF during pulmonary Pseudomonas aeruginosa infection. Blood 109:3235–3243PubMedCrossRefGoogle Scholar
  41. Hagihara K, Nishikawa T, Sugamata Y, Song J, Isobe T, Taga T, Yoshizaki K (2005) Essential role of STAT3 in cytokine-driven NF-kappaB-mediated serum amyloid A gene expression. Genes Cells 10:1051–1063PubMedCrossRefGoogle Scholar
  42. Hajjar AM, Harowicz H, Liggitt HD, Fink PJ, Wilson CB, Skerrett SJ (2005) An essential role for non-bone marrow-derived cells in control of Pseudomonas aeruginosa pneumonia. Am J Respir Cell Mol Biol 33:470–475PubMedCrossRefGoogle Scholar
  43. Han W, Joo M, Everhart MB, Christman JW, Yull FE, Blackwell TS (2009) Myeloid cells control termination of lung inflammation through the NF-kappaB pathway. Am J Physiol Lung Cell Mol Physiol 296:L320–L327PubMedCrossRefGoogle Scholar
  44. Happel KI, Dubin PJ, Zheng M, Ghilardi N, Lockhart C, Quinton LJ, Odden AR, Shellito JE, Bagby GJ, Nelson S, Kolls JK (2005) Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae. J Exp Med 202:761–769PubMedCrossRefGoogle Scholar
  45. Harris TJ, Grosso JF, Yen HR, Xin H, Kortylewski M, Albesiano E, Hipkiss EL, Getnet D, Goldberg MV, Maris CH, Housseau F, Yu H, Pardoll DM, Drake CG (2007) Cutting edge: an in vivo requirement for STAT3 signaling in TH17 development and TH17-dependent autoimmunity. J Immunol 179:4313–4317PubMedGoogle Scholar
  46. Hayden MS, Ghosh S (2008) Shared principles in NF-kappaB signaling. Cell 132:344–362PubMedCrossRefGoogle Scholar
  47. Hess C, Herr C, Beisswenger C, Zakharkina T, Schmid RM, Bals R (2010) Myeloid RelA regulates pulmonary host defense networks. Eur Respir J 35:343–352PubMedCrossRefGoogle Scholar
  48. Hokuto I, Ikegami M, Yoshida M, Takeda K, Akira S, Perl AK, Hull WM, Wert SE, Whitsett JA (2004) Stat-3 is required for pulmonary homeostasis during hyperoxia. J Clin Invest 113:28–37PubMedGoogle Scholar
  49. Holland SM, DeLeo FR, Elloumi HZ, Hsu AP, Uzel G, Brodsky N, Freeman AF, Demidowich A, Davis J, Turner ML, Anderson VL, Darnell DN, Welch PA, Kuhns DB, Frucht DM, Malech HL, Gallin JI, Kobayashi SD, Whitney AR, Voyich JM, Musser JM, Woellner C, Schaffer AA, Puck JM, Grimbacher B (2007) STAT3 mutations in the hyper-IgE syndrome. N Engl J Med 357:1608–1619PubMedCrossRefGoogle Scholar
  50. Hollingsworth JW, Chen BJ, Brass DM, Berman K, Gunn MD, Cook DN, Schwartz DA (2005) The critical role of hematopoietic cells in lipopolysaccharide-induced airway inflammation. Am J Respir Crit Care Med 171:806–813PubMedCrossRefGoogle Scholar
  51. Ikegami M, Falcone A, Whitsett JA (2008) STAT-3 regulates surfactant phospholipid homeostasis in normal lung and during endotoxin-mediated lung injury. J Appl Physiol 104:1753–1760PubMedCrossRefGoogle Scholar
  52. Jing Q, Huang S, Guth S, Zarubin T, Motoyama A, Chen J, Di Padova F, Lin SC, Gram H, Han J (2005) Involvement of microRNA in AU-rich element-mediated mRNA instability. Cell 120:623–634PubMedCrossRefGoogle Scholar
  53. Jones MR, Simms BT, Lupa MM, Kogan MS, Mizgerd JP (2005) Lung NF-{kappa}B activation and neutrophil recruitment require IL-1 and TNF receptor signaling during pneumococcal pneumonia. J Immunol 175:7530–7535PubMedGoogle Scholar
  54. Jones MR, Quinton LJ, Simms BT, Lupa MM, Kogan MS, Mizgerd JP (2006) Roles of interleukin-6 in activation of STAT proteins and recruitment of neutrophils during Escherichia coli pneumonia. J Infect Dis 193:360–369PubMedCrossRefGoogle Scholar
  55. Jones MR, Quinton LJ, Blahna MT, Neilson JR, Fu S, Ivanov AR, Wolf DA, Mizgerd JP (2009) Zcchc11-dependent uridylation of microRNA directs cytokine expression. Nat Cell Biol 11:1157–1163PubMedCrossRefGoogle Scholar
  56. Kida H, Mucenski ML, Thitoff AR, Le Cras TD, Park KS, Ikegami M, Muller W, Whitsett JA (2008) GP130-STAT3 regulates epithelial cell migration and is required for repair of the bronchiolar epithelium. Am J Pathol 172:1542–1554PubMedCrossRefGoogle Scholar
  57. Knapp S, Vos AF de, Florquin S, Golenbock DT, Poll T van der (2003) Lipopolysaccharide binding protein is an essential component of the innate immune response to Escherichia coli peritonitis in mice. Infect Immun 71:6747–6753PubMedCrossRefGoogle Scholar
  58. Kopf M, Baumann H, Freer G, Freudenberg M, Lamers M, Kishimoto T, Zinkernagel R, Bluethmann H, Kohler G (1994) Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 368:339–342PubMedCrossRefGoogle Scholar
  59. Ku CL, Bernuth H von, Picard C, Zhang SY, Chang HH, Yang K, Chrabieh M, Issekutz AC, Cunningham CK, Gallin J, Holland SM, Roifman C, Ehl S, Smart J, Tang M, Barrat FJ, Levy O, McDonald D, Day-Good NK, Miller R, Takada H, Hara T, Al-Hajjar S, Al-Ghonaium A, Speert D, Sanlaville D, Li X, Geissmann F, Vivier E, Marodi L, Garty BZ, Chapel H, Rodriguez-Gallego C, Bossuyt X, Abel L, Puel A, Casanova JL (2007) Selective predisposition to bacterial infections in IRAK-4-deficient children: IRAK-4-dependent TLRs are otherwise redundant in protective immunity. J Exp Med 204:2407–2422PubMedCrossRefGoogle Scholar
  60. Lang JE, Williams ES, Mizgerd JP, Shore SA (2008) Effect of obesity on pulmonary inflammation induced by acute ozone exposure: role of interleukin-6. Am J Physiol Lung Cell Mol Physiol 294:L1013–L1020PubMedCrossRefGoogle Scholar
  61. Lieschke GJ, Grail D, Hodgson G, Metcalf D, Stanley E, Cheers C, Fowler KJ, Basu S, Zhan YF, Dunn AR (1994) Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization. Blood 84:1737–1746PubMedGoogle Scholar
  62. Liu F, Wu HY, Wesselschmidt R, Kornaga T, Link DC (1996) Impaired production and increased apoptosis of neutrophils in granulocyte colony-stimulating factor receptor-deficient mice. Immunity 5:491–501PubMedCrossRefGoogle Scholar
  63. Liu G, Friggeri A, Yang Y, Park YJ, Tsuruta Y, Abraham E (2009) miR-147, a microRNA that is induced upon Toll-like receptor stimulation, regulates murine macrophage inflammatory responses. Proc Natl Acad Sci USA 106:15819–15824PubMedCrossRefGoogle Scholar
  64. Loffler D, Brocke-Heidrich K, Pfeifer G, Stocsits C, Hackermuller J, Kretzschmar AK, Burger R, Gramatzki M, Blumert C, Bauer K, Cvijic H, Ullmann AK, Stadler PF, Horn F (2007) Interleukin-6 dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer. Blood 110:1330–1333PubMedCrossRefGoogle Scholar
  65. Luedde T, Assmus U, Wustefeld T, Meyer zu Vilsendorf A, Roskams T, Schmidt-Supprian M, Rajewsky K, Brenner DA, Manns MP, Pasparakis M, Trautwein C (2005) Deletion of IKK2 in hepatocytes does not sensitize these cells to TNF-induced apoptosis but protects from ischemia/reperfusion injury. J Clin Invest 115:849–859PubMedGoogle Scholar
  66. Ma CS, Chew GY, Simpson N, Priyadarshi A, Wong M, Grimbacher B, Fulcher DA, Tangye SG, Cook MC (2008) Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3. J Exp Med 205:1551–1557PubMedCrossRefGoogle Scholar
  67. Ma'ayan A (2009) Insights into the organization of biochemical regulatory networks using graph theory analyses. J Biol Chem 284:5451–5455PubMedCrossRefGoogle Scholar
  68. Mancuso P, Gottschalk A, Phare SM, Peters-Golden M, Lukacs NW, Huffnagle GB (2002) Leptin-deficient mice exhibit impaired host defense in Gram-negative pneumonia. J Immunol 168:4018–4024PubMedGoogle Scholar
  69. Mancuso P, Huffnagle GB, Olszewski MA, Phipps J, Peters-Golden M (2006) Leptin corrects host defense defects after acute starvation in murine pneumococcal pneumonia. Am J Respir Crit Care Med 173:212–218PubMedCrossRefGoogle Scholar
  70. Matsuzaki Y, Xu Y, Ikegami M, Besnard V, Park KS, Hull WM, Wert SE, Whitsett JA (2006) Stat3 is required for cytoprotection of the respiratory epithelium during adenoviral infection. J Immunol 177:527–537PubMedGoogle Scholar
  71. McCoy CE, Sheedy FJ, Qualls JE, Doyle SL, Quinn SR, Murray PJ, O'Neill LA (2010) IL-10 inhibits miR-155 induction by toll-like receptors. J Biol Chem 285:20492–20498PubMedCrossRefGoogle Scholar
  72. McLemore ML, Grewal S, Liu F, Archambault A, Poursine-Laurent J, Haug J, Link DC (2001) STAT-3 activation is required for normal G-CSF-dependent proliferation and granulocytic differentiation. Immunity 14:193–204PubMedCrossRefGoogle Scholar
  73. Meek RL, Benditt EP (1986) Amyloid A gene family expression in different mouse tissues. J Exp Med 164:2006–2017PubMedCrossRefGoogle Scholar
  74. Mills KH (2008) Induction, function and regulation of IL-17-producing T cells. Eur J Immunol 38:2636–2649PubMedCrossRefGoogle Scholar
  75. Milner JD, Brenchley JM, Laurence A, Freeman AF, Hill BJ, Elias KM, Kanno Y, Spalding C, Elloumi HZ, Paulson ML, Davis J, Hsu A, Asher AI, O'Shea J, Holland SM, Paul WE, Douek DC (2008) Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature 452:773–776PubMedCrossRefGoogle Scholar
  76. Minegishi Y, Saito M, Tsuchiya S, Tsuge I, Takada H, Hara T, Kawamura N, Ariga T, Pasic S, Stojkovic O, Metin A, Karasuyama H (2007) Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature 448:1058–1062PubMedCrossRefGoogle Scholar
  77. Mizgerd JP (2006) Lung infection—a public health priority. PLoS Med 3:e76PubMedCrossRefGoogle Scholar
  78. Mizgerd JP (2008) Acute lower respiratory tract infection. N Engl J Med 358:716–727PubMedCrossRefGoogle Scholar
  79. Mizgerd JP, Spieker MR, Doerschuk CM (2001) Early response cytokines and innate immunity: essential roles for TNF receptor 1 and type I IL-1 receptor during Escherichia coli pneumonia in mice. J Immunol 166:4042–4048PubMedGoogle Scholar
  80. Mizgerd JP, Scott ML, Spieker MR, Doerschuk CM (2002) Functions of IkB proteins in inflammatory responses to E. coli LPS in mouse lungs. Am J Respir Cell Mol Biol 27:575–582PubMedGoogle Scholar
  81. Mizgerd JP, Lupa MM, Kogan MS, Warren HB, Kobzik L, Topulos GP (2003) Nuclear factor-kB p50 limits inflammation and prevents lung injury during Escherichia coli pneumonia. Am J Respir Crit Care Med 168:810–817PubMedCrossRefGoogle Scholar
  82. Mizgerd JP, Lupa MM, Spieker MS (2004a) NF-kappaB p50 facilitates neutrophil accumulation during LPS-induced pulmonary inflammation. BMC Immunol 5:10PubMedCrossRefGoogle Scholar
  83. Mizgerd JP, Lupa MM, Hjoberg J, Vallone JC, Warren HB, Butler JP, Silverman ES (2004b) Roles for early response cytokines during Escherichia coli pneumonia revealed by mice with combined deficiencies of all signaling receptors for TNF and IL-1. Am J Physiol Lung Cell Mol Physiol 286:L1302–L1310PubMedCrossRefGoogle Scholar
  84. Mold C, Nakayama S, Holzer TJ, Gewurz H, Du Clos TW (1981) C-reactive protein is protective against Streptococcus pneumoniae infection in mice. J Exp Med 154:1703–1708PubMedCrossRefGoogle Scholar
  85. Nelson S, Bagby GJ, Bainton BG, Wilson LA, Thompson JJ, Summer WR (1989) Compartmentalization of intraalveolar and systemic lipopolysaccharide-induced tumor necrosis factor and the pulmonary inflammatory response. J Infect Dis 159:189–194PubMedGoogle Scholar
  86. O'Connell RM, Rao DS, Chaudhuri AA, Baltimore D (2010) Physiological and pathological roles for microRNAs in the immune system. Nat Rev Immunol 10:111–122PubMedCrossRefGoogle Scholar
  87. O'Grady NP, Preas HL, Pugin J, Fiuza C, Tropea M, Reda D, Banks SM, Suffredini AF (2001) Local inflammatory responses following bronchial endotoxin instillation in humans. Am J Respir Crit Care Med 163:1591–1598PubMedGoogle Scholar
  88. Pahl HL (1999) Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 18:6853–6866PubMedCrossRefGoogle Scholar
  89. Panopoulos AD, Watowich SS (2008) Granulocyte colony-stimulating factor: molecular mechanisms of action during steady state and “emergency” hematopoiesis. Cytokine 42:277–288PubMedCrossRefGoogle Scholar
  90. Panopoulos AD, Zhang L, Snow JW, Jones DM, Smith AM, El Kasmi KC, Liu F, Goldsmith MA, Link DC, Murray PJ, Watowich SS (2006) STAT3 governs distinct pathways in emergency granulopoiesis and mature neutrophils. Blood 108:3682–3690PubMedCrossRefGoogle Scholar
  91. Patel DN, King CA, Bailey SR, Holt JW, Venkatachalam K, Agrawal A, Valente AJ, Chandrasekar B (2007) Interleukin-17 stimulates C-reactive protein expression in hepatocytes and smooth muscle cells via p38 MAPK and ERK1/2-dependent NF-kappaB and C/EBPbeta activation. J Biol Chem 282:27229–27238PubMedCrossRefGoogle Scholar
  92. Pennington JE (1986) Gram-negative bacterial pneumonia in the immunocompromised host. Semin Respir Infect 1:145–150PubMedGoogle Scholar
  93. Poll T van der, Keogh CV, Guirao X, Buurman WA, Kopf M, Lowry SF (1997) Interleukin-6 gene-deficient mice show impaired defense against pneumococcal pneumonia. J Infect Dis 176:439–444PubMedCrossRefGoogle Scholar
  94. Poynter ME, Irvin CG, Janssen-Heininger YM (2003) A prominent role for airway epithelial NF-kappa B activation in lipopolysaccharide-induced airway inflammation. J Immunol 170:6257–6265PubMedGoogle Scholar
  95. Quinton LJ, Nelson S, Boe DM, Zhang P, Zhong Q, Kolls JK, Bagby GJ (2002) The granulocyte colony-stimulating factor response after intrapulmonary and systemic bacterial challenges. J Infect Dis 185:1476–1482PubMedCrossRefGoogle Scholar
  96. Quinton LJ, Jones MR, Simms BT, Kogan MS, Robson BE, Skerrett SJ, Mizgerd JP (2007) Functions and regulation of NF-kappaB RelA during pneumococcal pneumonia. J Immunol 178:1896–1903PubMedGoogle Scholar
  97. Quinton LJ, Jones MR, Robson BE, Simms BT, Whitsett JA, Mizgerd JP (2008) Alveolar epithelial STAT3, IL-6 family cytokines, and host defense during Escherichia coli pneumonia. Am J Respir Cell Mol Biol 38:699–706PubMedCrossRefGoogle Scholar
  98. Quinton LJ, Jones MR, Robson BE, Mizgerd JP (2009) Mechanisms of the hepatic acute-phase response during bacterial pneumonia. Infect Immun 77:2417–2426PubMedCrossRefGoogle Scholar
  99. Rehm SR, Gross GN, Pierce AK (1980) Early bacterial clearance from murine lungs. Species-dependent phagocyte response. J Clin Invest 66:194–199PubMedCrossRefGoogle Scholar
  100. Ruminy P, Gangneux C, Claeyssens S, Scotte M, Daveau M, Salier JP (2001) Gene transcription in hepatocytes during the acute phase of a systemic inflammation: from transcription factors to target genes. Inflamm Res 50:383–390PubMedCrossRefGoogle Scholar
  101. Sakamori R, Takehara T, Ohnishi C, Tatsumi T, Ohkawa K, Takeda K, Akira S, Hayashi N (2007) Signal transducer and activator of transcription 3 signaling within hepatocytes attenuates systemic inflammatory response and lethality in septic mice. Hepatology 46:1564–1573PubMedCrossRefGoogle Scholar
  102. Schindler C, Levy DE, Decker T (2007) JAK-STAT signaling: from interferons to cytokines. J Biol Chem 282:20059–20063PubMedCrossRefGoogle Scholar
  103. Severgnini M, Takahashi S, Rozo LM, Homer RJ, Kuhn C, Jhung JW, Perides G, Steer M, Hassoun PM, Fanburg BL, Cochran BH, Simon AR (2004) Activation of the STAT pathway in acute lung injury. Am J Physiol Lung Cell Mol Physiol 286:L1282–L1292PubMedCrossRefGoogle Scholar
  104. Sha WC, Liou H, Tuomanen EI, Baltimore D (1995) Targeted disruption of the p50 subunit of NF-kB leads to multifocal defects in immune responses. Cell 80:321–330PubMedCrossRefGoogle Scholar
  105. Shahbazian LM, Quinton LJ, Bagby GJ, Nelson S, Wang G, Zhang P (2004) Escherichia coli pneumonia enhances granulopoiesis and the mobilization of myeloid progenitor cells into the systemic circulation. Crit Care Med 32:1740–1746PubMedCrossRefGoogle Scholar
  106. Sheedy FJ, Palsson-McDermott E, Hennessy EJ, Martin C, O'Leary JJ, Ruan Q, Johnson DS, Chen Y, O'Neill LA (2010) Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21. Nat Immunol 11:141–147PubMedCrossRefGoogle Scholar
  107. Shimada K, Chen S, Dempsey PW, Sorrentino R, Alsabeh R, Slepenkin AV, Peterson E, Doherty TM, Underhill D, Crother TR, Arditi M (2009) The NOD/RIP2 pathway is essential for host defenses against Chlamydophila pneumoniae lung infection. PLoS Pathog 5:e1000379PubMedCrossRefGoogle Scholar
  108. Skerrett SJ, Liggitt HD, Hajjar AM, Wilson CB (2004a) Cutting edge: myeloid differentiation factor 88 is essential for pulmonary host defense against Pseudomonas aeruginosa but not Staphylococcus aureus. J Immunol 172:3377–3381PubMedGoogle Scholar
  109. Skerrett SJ, Liggitt HD, Hajjar AM, Ernst RK, Miller SI, Wilson CB (2004b) Respiratory epithelial cells regulate lung inflammation in response to inhaled endotoxin. Am J Physiol Lung Cell Mol Physiol 287:L143–L152PubMedCrossRefGoogle Scholar
  110. Smith RP, Lipworth BJ, Cree IA, Spiers EM, Winter JH (1995) C-reactive protein. A clinical marker in community-acquired pneumonia. Chest 108:1288–1291PubMedCrossRefGoogle Scholar
  111. Sun J, Madan R, Karp CL, Braciale TJ (2009a) Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10. Nat Med 15:277–284PubMedCrossRefGoogle Scholar
  112. Sun L, Guo RF, Newstead MW, Standiford TJ, Macariola DR, Shanley TP (2009b) Effect of IL-10 on neutrophil recruitment and survival after Pseudomonas aeruginosa challenge. Am J Respir Cell Mol Biol 41:76–84PubMedCrossRefGoogle Scholar
  113. Taganov KD, Boldin MP, Chang KJ, Baltimore D (2006) NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA 103:12481–12486PubMedCrossRefGoogle Scholar
  114. Takeda K, Noguchi K, Shi W, Tanaka T, Matsumoto M, Yoshida N, Kishimoto T, Akira S (1997) Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc Natl Acad Sci USA 94:3801–3804PubMedCrossRefGoogle Scholar
  115. Takeda K, Kaisho T, Yoshida N, Takeda J, Kishimoto T, Akira S (1998) Stat3 activation is responsible for IL-6-dependent T cell proliferation through preventing apoptosis: generation and characterization of T cell-specific Stat3-deficient mice. J Immunol 161:4652–4660PubMedGoogle Scholar
  116. Takeda K, Clausen BE, Kaisho T, Tsujimura T, Terada N, Forster I, Akira S (1999) Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity 10:39–49PubMedCrossRefGoogle Scholar
  117. Tal G, Mandelberg A, Dalal I, Cesar K, Somekh E, Tal A, Oron A, Itskovich S, Ballin A, Houri S, Beigelman A, Lider O, Rechavi G, Amariglio N (2004) Association between common Toll-like receptor 4 mutations and severe respiratory syncytial virus disease. J Infect Dis 189:2057–2063PubMedCrossRefGoogle Scholar
  118. Taylor GA, Carballo E, Lee DM, Lai WS, Thompson MJ, Patel DD, Schenkman DI, Gilkeson GS, Broxmeyer HE, Haynes BF, Blackshear PJ (1996) A pathogenetic role for TNF alpha in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency. Immunity 4:445–454PubMedCrossRefGoogle Scholar
  119. Thorn CF, Lu ZY, Whitehead AS (2004) Regulation of the human acute phase serum amyloid A genes by tumour necrosis factor-alpha, interleukin-6 and glucocorticoids in hepatic and epithelial cell lines. Scand J Immunol 59:152–158PubMedCrossRefGoogle Scholar
  120. Tillett WS, Francis T (1930) Serological reactions in pneumonia with non-protein somatic fraction of pneumococcus. J Exp Med 52:561–571PubMedCrossRefGoogle Scholar
  121. Tsai WC, Strieter RM, Mehrad B, Newstead MW, Zeng X, Standiford TJ (2000) CXC chemokine receptor CXCR2 is essential for protective innate host response in murine Pseudomonas aeruginosa pneumonia. Infect Immun 68:4289–4296PubMedCrossRefGoogle Scholar
  122. Uskokovic A, Dinic S, Mihailovic M, Grigorov I, Ivanovic-Matic S, Bogojevic D, Grdovic N, Arambasic J, Vidakovic M, Martinovic V, Petrovic M, Poznanovic G (2007) STAT3/NFkappaB interplay in the regulation of alpha2-macroglobulin gene expression during rat liver development and the acute phase response. IUBMB Life 59:170–178PubMedCrossRefGoogle Scholar
  123. Vernooy JH, Reynaert N, Wolfs TG, Cloots RH, Haegens A, Vries B de, Dentener MA, Buurman WA, Wouters EM (2005) Rapid pulmonary expression of acute-phase reactants after local lipopolysaccharide exposure in mice is followed by an interleukin-6 mediated systemic acute-phase response. Exp Lung Res 31:855–871PubMedCrossRefGoogle Scholar
  124. Wang E, Bergeron Y, Bergeron MG (2005) Ceftriaxone pharmacokinetics in interleukin-10-treated murine pneumococcal pneumonia. J Antimicrob Chemother 55:721–726PubMedCrossRefGoogle Scholar
  125. Ware LB, Matthay MA (2000) The acute respiratory distress syndrome. N Engl J Med 342:1334–1349PubMedCrossRefGoogle Scholar
  126. Wegrzyn J, Potla R, Chwae YJ, Sepuri NB, Zhang Q, Koeck T, Derecka M, Szczepanek K, Szelag M, Gornicka A, Moh A, Moghaddas S, Chen Q, Bobbili S, Cichy J, Dulak J, Baker DP, Wolfman A, Stuehr D, Hassan MO, Fu XY, Avadhani N, Drake JI, Fawcett P, Lesnefsky EJ, Larner AC (2009) Function of mitochondrial Stat3 in cellular respiration. Science 323:793–797PubMedCrossRefGoogle Scholar
  127. Welte K, Gabrilove J, Bronchud MH, Platzer E, Morstyn G (1996) Filgrastim (r-metHuG-CSF): the first 10 years. Blood 88:1907–1929PubMedGoogle Scholar
  128. Winkelstein JA, Marino MC, Johnston RB Jr, Boyle J, Curnutte J, Gallin JI, Malech HL, Holland SM, Ochs H, Quie P, Buckley RH, Foster CB, Chanock SJ, Dickler H (2000) Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore) 79:155–169CrossRefGoogle Scholar
  129. Wolk K, Witte E, Witte K, Warszawska K, Sabat R (2010) Biology of interleukin-22. Semin Immunopathol 32:17–31PubMedCrossRefGoogle Scholar
  130. Wurfel MM, Gordon AC, Holden TD, Radella F, Strout J, Kajikawa O, Ruzinski JT, Rona G, Black RA, Stratton S, Jarvik GP, Hajjar AM, Nickerson DA, Rieder M, Sevransky J, Maloney JP, Moss M, Martin G, Shanholtz C, Garcia JG, Gao L, Brower R, Barnes KC, Walley KR, Russell JA, Martin TR (2008) Toll-like receptor 1 polymorphisms affect innate immune responses and outcomes in sepsis. Am J Respir Crit Care Med 178:710–720PubMedCrossRefGoogle Scholar
  131. Yano K, Liaw PC, Mullington JM, Shih SC, Okada H, Bodyak N, Kang PM, Toltl L, Belikoff B, Buras J, Simms BT, Mizgerd JP, Carmeliet P, Karumanchi SA, Aird WC (2006) Vascular endothelial growth factor is an important determinant of sepsis morbidity and mortality. J Exp Med 203:1447–1458PubMedCrossRefGoogle Scholar
  132. Ye P, Rodriguez FH, Kanaly S, Stocking KL, Schurr J, Schwarzenberger P, Oliver P, Huang W, Zhang P, Zhang J, Shellito JE, Bagby GJ, Nelson S, Charrier K, Peschon JJ, Kolls JK (2001) Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J Exp Med 194:519–527PubMedCrossRefGoogle Scholar
  133. Yip TT, Chan JW, Cho WC, Yip TT, Wang Z, Kwan TL, Law SC, Tsang DN, Chan JK, Lee KC, Cheng WW, Ma VW, Yip C, Lim CK, Ngan RK, Au JS, Chan A, Lim WW (2005) Protein chip array profiling analysis in patients with severe acute respiratory syndrome identified serum amyloid a protein as a biomarker potentially useful in monitoring the extent of pneumonia. Clin Chem 51:47–55PubMedCrossRefGoogle Scholar
  134. Yuste J, Botto M, Bottoms SE, Brown JS (2007) Serum amyloid P aids complement-mediated immunity to Streptococcus pneumoniae. PLoS Pathog 3:1208–1219PubMedCrossRefGoogle Scholar
  135. Zahedi K, Whitehead AS (1993) Regulation of mouse serum amyloid P gene expression by cytokines in vitro. Biochim Biophys Acta 1176:162–168PubMedCrossRefGoogle Scholar
  136. Zhong Z, Wen Z, Darnell JE Jr (1994) Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science 264:95–98PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  1. 1.The Pulmonary CenterBoston University School of MedicineBostonUSA

Personalised recommendations